Nakayama et al 1 have described an interesting polymorphism in the NPR-A gene in a Japanese population. An 8-nucleotide deletion in the 5Ј untranslated region (UTR) of the gene was found to be associated with essential hypertension and left ventricular hypertrophy in a study of 200 hypertensive (HT) and 200 normotensive (NT) subjects. The polymorphism occurred at a frequency of 4% in the HT patients and in a single NT subject (0.5%) who was subsequently found to have left ventricular hypertrophy. Carriers of the functional deletion (D) allele had higher plasma BNP levels, a strong marker of cardiac stress, than those with the wild-type allele. Expression of NPR-A from the D allele was reduced compared with the wild-type allele and it is suggested that the deletion interferes with binding of regulatory factors to the 5Ј UTR of the gene. 1 We screened 498 patients from the Christchurch Post-Myocardial Infarction (PMI) Study 2-4 who had acute myocardial infarction for the NPR-A D allele. DNA samples were amplified using the polymerase chain reaction primers hNPR-Af 5Јacgcgcctgatgcctgg-gac3Ј and hNPR-Ar 5Јcagtaccacggctaccgtcaggtt3Ј and the wild-type (I ) and D amplimers (216 and 208 bp, respectively) were resolved on 3% agarose, 0.5 ϫ TBE gels and visualized using ethidium bromide and a Bio-Rad Fluor-S imaging system (Hercules, Calif). Patient DNA samples with (nϭ3) and without (nϭ3) the functional deletion from the Japanese study were used as controls. 1 The New Zealand patients were 75% male, with a mean age of 62.4 (Ϯ0.5) years, 15.0% had a history of previous myocardial infarction, 52.0% had or were being treated for hypertension, 60.4% were past or present smokers, 11.4% had diabetes, 1.6% had had congestive heart failure, 52.7% were being treated with ␤-blockers, and 31.7% were being treated with an angiotensin-converting enzyme inhibitor; 83.3% were of European ethnicity, 3.8% Maori, 1.2% other (Indian, Middle Eastern, Pacific Islanders), and 11.7% not stated.
